傳藝科技(002866.SZ)擬回購註銷22.72萬股限制性股票及註銷34.68萬份股票期權
格隆匯1月14日丨傳藝科技(002866.SZ)公佈,,鑑於公司《激勵計劃》的首次授予激勵對象16人已經離職,同意將上述激勵對象已獲授但尚未解鎖的限制性股票合計22.72萬股進行回購註銷,佔授予限制性股票總量的4.97%;並將其已獲授但尚未獲準行權的合計34.68萬份股票期權進行註銷,佔授予股票期權總量的5.10%。
根據公司《激勵計劃》,本次回購註銷限制性股票的價格為5.62元/股加上銀行同期存款利息之和。公司將使用自有資金進行回購。
本次回購註銷完成後,公司總股本將由247,775,390股變更為248,470,790股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.